Company Quick10K Filing
FCCC
10-Q 2019-12-31 Filed 2020-02-13
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-13
10-K 2019-03-31 Filed 2019-06-27
10-Q 2018-12-31 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-13
10-Q 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-11
10-K 2017-03-31 Filed 2017-06-19
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-12
10-K 2016-03-31 Filed 2016-06-17
10-Q 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-K 2015-03-31 Filed 2015-06-30
10-Q 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-12-31 Filed 2014-02-07
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-01
10-K 2013-03-31 Filed 2013-06-14
10-Q 2012-12-31 Filed 2013-02-08
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-03
10-K 2012-03-31 Filed 2012-06-12
10-Q 2011-12-31 Filed 2012-02-09
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-07-29
10-K 2011-03-31 Filed 2011-06-13
10-Q 2010-12-31 Filed 2011-02-07
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-06
10-K 2010-03-31 Filed 2010-06-14
10-Q 2009-12-31 Filed 2010-02-12

FCCC Financials

FCCC Metrics, Comps, Filings

Quarterly | Annual

Business

FCCC, Inc. (OTC.QB "FCIC") was incorporated under the laws of the State of Connecticut on May 6, 1960 under the name The First Connecticut Small Business Investment Company. The Company changed its name to The First Connecticut Capital Corporation on January 27, 1993, and then to FCCC, Inc. on June 4, 2003. The Company maintains its principal executive offices at 1650 West 106th Street, Carmel, Indiana, 46203, Telephone Number 317-860-8213. FCCC is authorized to issue 22,000,000 shares of common stock, no par value. The Company had 3,461,022 shares of common stock issued and outstanding at March 31, 2019.

The Company has had limited operations since June 30, 2003, and is a "shell company" as defined in Rule 13b-2 of the Exchange Act. Such operations consist of a search for appropriate transactions such as a merger, acquisition, reverse merger or other business combination with an operating business or other appropriate financial transaction. See "Current Business" below.

Since June 2003, the Company's operations consist of a search for a merger, acquisition, reverse merger or a business transaction opportunity with an operating business or other financial transaction; however, there can be no assurance that this plan will be successfully implemented. Until a transaction is effectuated, the Company does not expect to have significant operations. Accordingly, during this period we do not expect to achieve sufficient income to offset our operating expenses, resulting in operating losses that may require us to use and thereby reduce our limited cash balance. Until we complete a merger, reverse merger or other financial transaction, and unless interest rates increase dramatically, we expect to incur a loss of between $15,000 to $18,000 for the first quarter and thereafter of between $11,000 to $13,000 per quarter. The increase in first quarter expenses relates to a Company audit and tax return. At this time, the Company has no binding arrangements with respect to any potential merger, acquisition, reverse merger or business combination candidate pursuant to which it may become an operating company.


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Stemcell Holdings (STMM) 113% -1.0 26% 12,032,848,000 6,023,444,000 7,313,554,000 8,234,525,000 3,099,084,000 4,927,199,000 -5,115,749,000
FCCC (FCCC) 1.5 -61% 92,000,000 3,000,000 0 0 -56,000,000 -56,000,000 -82,002,000
Tapinator (TAPM) 0% 0.1 -99% 1,783,274,000 951,832,000 4,322,948,000 0 -1,761,567,000 -1,761,567,000 -260,211,000
Nogales Resources (NLRT) 0% 517,000 187,974,000 0 0 0 0 -519,000
Golden Growers Cooperative (GGRO) -0% 0% 26,919,000,000 2,171,000,000 42,425,000,000 -45,000,000 0 0 -3,508,002,000
Northern Power Systems (NPS) 22% 0.4 -27% 8,927,000,000 13,901,000,000 18,317,000,000 4,050,000,000 -2,379,000,000 -1,701,000,000 -670,002,000
Twin River Worldwide (TRWH) 0% 4.0 4% 1,070,918,000,000 808,153,000,000 393,158,000,000 0 41,775,000,000 112,100,000,000 449,559,999,000
Bio-En (BENH) 0.1 -643% 10,396,000 149,279,000 0 0 -66,818,000 -66,818,000 -4,687,000
Southwest Iowa Renewable Energy (SIRE) -1% -47.3 -1% 140,863,000,000 51,558,000,000 216,993,000,000 -1,931,000,000 -1,169,518,000 -536,518,000 25,395,999,000
Texas Republic Capital (TRCC) 0% 8.9 -5% 26,314,961,000 14,988,148,000 930,677,000 0 -1,274,149,000 -1,274,149,000 -11,327,584,000
Fannie Mae (FNM) 28.1 0% 3,494,436,000,000,000 3,484,094,000,000,000 0 0 13,025,000,000,000 119,732,000,000,000 3,361,547,999,999,000
CBA Florida (CBAI) 43.6 -1% 14,544,469,000 597,854,000 0 0 -210,911,000 -260,844,000 -11,367,563,000
Pacific Gold & Royalty (PCFG) -7.1 0 3,799,496,000 0 -2,545,000 -238,328,000 -45,194,000 319,839,000
BoxScore Brands (BOXS) 33% -8.3 -540% 312,912,000 7,564,280,000 338,295,000 110,302,000 -1,690,277,000 -701,925,000 5,793,309,000
Quest Management (QUEST) 27% -0.3 129% 12,526,000 6,028,000 45,177,000 12,318,000 16,132,000 16,164,000 -5,306,000
Zhen Ding Resources (RBTK) 0.1 48,309,900% 0 0 -483,099,000 -68,261,000 -6,097,000
Hines Global REIT (HGRI) 0% 1.7 19% 2,010,946,000,000 999,520,000,000 205,149,000,000 0 388,366,000,000 421,651,000,000 715,766,999,000
Wadena (WDN) 0% 0.0 -2,344% 11,999,000 696,137,000 87,000,000 0 -281,214,000 -278,021,000 -5,132,000
Galera Therapeutics (GRTX) 1.3 -17% 79,758,000,000 52,298,000,000 0 0 -13,351,000,000 -12,433,000,000 -15,719,002,000
Chase General (CSGN) 26% -0.5 -2% 1,563,342,000 1,016,098,000 2,493,194,000 657,636,000 -32,054,000 13,371,000 -6,929,000

Balance Sheet ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash167,000,000144,000,000130,000,000117,000111,000,00098,000,00088,000,00079,000,00074,000,00067,000,00050,000,00042,000,00032,000,000368,000,000345,000,000337,000,000326,000,000309,000,000300,000,000293,000,000276,000,000260,000,000250,000,000243,000,000223,000,000205,000,000199,000,000188,000,000149,000,000139,000,000130,000,000120,000,00094,000,00082,000,000
Accounts Receivable
Inventory
PP&E
Assets145,000,000131,000,000118,000112,000,00099,000,00089,000,00080,000,00075,000,00068,000,00051,000,00043,000,00033,000,000372,000,000347,000,000337,000,000333,000,000315,000,000304,000,000295,000,000286,000,000268,000,000255,000,000246,000,000233,000,000214,000,000204,000,000191,000,000162,000,000148,000,000136,000,000123,000,000106,000,00092,000,000
Accounts Payable
Long-Term Debt
Liabilities8,000,0009,000,00010,00013,000,0009,000,0009,000,0009,000,00012,000,00013,000,0009,000,00015,000,00032,000,00010,000,0001,000,0001,000,00010,000,0002,000,0002,000,0003,000,00011,000,0003,000,0002,000,0003,000,0004,000,0002,000,0004,000,00019,000,0006,000,0003,000,0004,000,0008,000,0007,000,0003,000,000
Stockholders' Equity137,000,000122,000,000108,00099,000,00090,000,00080,000,00071,000,00063,000,00055,000,00042,000,00028,000,0001,000,000362,000,000346,000,000336,000,000323,000,000313,000,000302,000,000292,000,000275,000,000265,000,000253,000,000243,000,000229,000,000212,000,000200,000,000172,000,000156,000,000145,000,000132,000,000115,000,00099,000,00089,000,000
Income Statement ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A11,000,00017,000,00014,000,000-41,947,0007,000,0008,000,0008,000,0007,000,0006,000,0006,000,00011,000,0007,000,00027,000,00035,000,00016,000,000-17,000,00013,000,00010,000,00011,000,000-20,000,00017,000,00010,000,00012,000,000-21,000,00014,000,00019,000,00012,000,000-21,000,00016,000,00015,000,00013,000,000-17,000,00016,000,00010,000,000
Tax00000000000000000000000000000
Net Income-13,000,000-18,000,000-15,000,00045,940,000-9,000,000-3,000,000-10,000,000-9,000,000-8,000,000-8,000,000-13,000,000-14,000,000-27,000,000-19,000,000-16,000,000-10,000,000-13,000,000-10,000,000-11,000,000-10,000,000-17,000,000-10,000,000-12,000,000-10,000,000-14,000,000-19,000,000-12,000,000-28,000,000-16,000,000-11,000,000-13,000,000-17,000,000-16,000,000-10,000,000
Cash Flow ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-12,000,000-23,000,000-14,000,00048,938,000-6,000,000-13,000,000-10,000,000-9,000,000-5,000,000-7,000,000-17,000,000-8,000,000-10,000,000-44,000,000-23,000,000-8,000,000-11,000,000-17,000,000-9,000,000-7,000,000-17,000,000-16,000,000-10,000,000-7,000,000-20,000,000-18,000,000-6,000,000-11,000,000-39,000,000-10,000,000-10,000,000-26,000,000-12,000,000
Cash Investing0
Cash Financing00000